ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to slow advanced breast cancer after standard treatment fails
Disease control OngoingThis study tests whether a new drug (PF-07220060) combined with fulvestrant works better than standard treatments for people with advanced or metastatic HR+/HER2- breast cancer that has worsened after prior CDK4/6 inhibitor therapy. About 333 adults will be randomly assigned to r…
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 11:39 UTC
-
New drug shows promise for Hard-to-Treat breast cancer in major trial
Disease control OngoingThis study tests a new drug, trastuzumab deruxtecan (T-DXd), against standard chemotherapy in 866 people with a common type of advanced breast cancer (HER2-low, hormone receptor-positive) that stopped responding to hormone therapy. The goal is to see if T-DXd can slow cancer grow…
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 13:50 UTC